Liminatus Pharma, Inc. (LIMN)
NASDAQ: LIMN · Real-Time Price · USD
5.93
-0.34 (-5.42%)
At close: Aug 1, 2025, 4:00 PM
5.94
+0.01 (0.17%)
After-hours: Aug 1, 2025, 7:56 PM EDT

Liminatus Pharma Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22
Cash & Equivalents
-0.060.435.05
Cash & Short-Term Investments
-0.060.435.05
Cash Growth
--87.10%-91.40%-
Other Receivables
--0.130.1
Receivables
-3.670.950.1
Prepaid Expenses
-0.160.020.01
Other Current Assets
-1.40.841.68
Total Current Assets
-5.282.246.84
Property, Plant & Equipment
-000
Other Long-Term Assets
-0.13--
Total Assets
-5.412.246.84
Accounts Payable
-1.480.930.51
Accrued Expenses
03.10.860.44
Short-Term Debt
-19.9716.0516.5
Other Current Liabilities
-0.20.20.2
Total Current Liabilities
024.7518.0417.65
Total Liabilities
024.7518.0417.65
Common Stock
-4.714.714.17
Additional Paid-In Capital
04.614.615.16
Retained Earnings
-0-28.67-25.12-20.14
Shareholders' Equity
-0-19.34-15.79-10.81
Total Liabilities & Equity
-5.412.246.84
Total Debt
-19.9716.0516.5
Net Cash (Debt)
--19.92-15.62-11.45
Net Cash Per Share
--0.18-0.15-0.32
Filing Date Shares Outstanding
26.01112.22112.2235.56
Total Common Shares Outstanding
26.01112.22112.2235.56
Working Capital
-0-19.47-15.8-10.81
Book Value Per Share
-0.00-0.17-0.14-0.30
Tangible Book Value
-0-19.34-15.79-10.81
Tangible Book Value Per Share
-0.00-0.17-0.14-0.30
Source: S&P Global Market Intelligence. Standard template. Financial Sources.